UK). He was also treated with a short-stretch bandage (Comprilan1, Beiersdorf AG, Germany), there was no evident oedema. The ulcer progressed despite the treatment, without any signs of healing. He has not received any antibiotic treatment for the MRSA.
In September 1997, the patient was introduced to larval therapy. The total size of the ulcer was 470 cm 2 (F|g. 1). A ring of hydrocolloid dressing (Duoderm1, ConvaTec Ltd, UK) was applied to the intact skin around the ulcer edges (F|g. 2) to protect the skin surrounding the ulcer from the potent proteolytic enzymes in the larval secretions and to minimize the tickling sensation of the larval movements. About 200 larvae, 1^2 mm long were placed in the ulcer (F|g. 2). The ulcer was then covered with a net to avoid larval escape. A top dressing of gauze soaked in saline was placed over the net and held in place with dry gauze. The top dressing was changed after 24 h to a dry gauze dressing and this was changed every 24 h for 3 days, after which the fully grown larvae were removed. The yellowish-green necrosis in the ulcer was removed by the larvae and healthy pinkish granulation tissue could be seen. Larvae are usually £ushed down the drain, but since these larvae could hold MRSA, they were dealt with as contagious material.
The ulcer treatment was continued with cadexomer iodine and a short-stretch bandage three times a week, and now the ulcer started to heal. The patient, who initially had been sceptical about the therapy, was now enthusiastic as the ulcer showed improvement.
Another larval application was administered in November 1997. For 3 days the larvae remained in the ulcer without any discomfort to the patient.Twodays afterremovalofthe larvae aswabfromtheulcer showed that the MRSA had lost its speci¢c resistance-gene due to mutation.
The patient then received a third and ¢nal larval treatment shortly after the second one. This time, however, the patient experienced pain after 2 days of therapy and the larvae were removed. Some of them were fully grown and some were small, indicating that there had been little to feed on in the ulcer. The ulcer appeared to be well debrided. The ulcer was then treated as before, with cadexomer iodine and shortstretch compression bandages. Further swabs did not show any signs of MRSA but only of common S. aureus. The ulcer size continued to decrease to 8 cm 2 in August 1998 and proceeded to complete healing in November 1998 (F|gs 1 and 3) . The pain decreased considerably, now su¤ciently being controlled by analgesics. The patient was o¡ered vascular reconstructive surgery as he no longer carried MRSA, but he turned the o¡er down as the pain was bearable. 
DISCUSSION
Many ulcers have a multifactorial origin, which makes them di¤cult to treat. We believe that larvae of the blow£y have a place in modern management of di¤cult-to-treat ulcers. Lucilia sericata is the most common larval species used, since they feed on necrotic tissue and leave viable tissue alone. Larval therapy is useful in patients with foul-smelling necrotic ulcers such as gangrene (leg and foot ulcers and decubitus ulcers) needing e¤cient rapid debridement but has also been suggested to speed ulcer healing (3^7). During the 1930s and 1940s, before the antibiotic era, larval therapy was commonly employed by surgeons in the USA and Europe when treating deep bone or soft-tissue infections (4, 8) . However, since the advent of antibiotics larval therapy has been little used. Today most physicians in developed countries are unaccustomed to untreatable bacterial diseases (9) . Evolution of bacterial strains resistant to antibiotics is a growing problem and we might need to look for alternative treatments to antibiotics. S. aureus is the most common bacterial strain found in leg ulcers (10) .
The treatment of choice for MRSA infections is a glucopeptide antibiotic, i.e. teicoplanin or vancomycin (1). This treatment is, however, used only when there are obvious signs of an infection. If MRSA without signs of infection is found, antibiotics should be avoided altogether.
In this case we cannot say with certainty whether the MRSA would have mutated spontaneously without larval therapy. The larvae did, however, induce a healing process in an ulcer of multifactorial origin and reduced the pain of the ulcer. In all probability, the larvae also reduced the amount of bacteria.
There are several mechanisms a¡ecting bacteria, which grow on necrotic tissue. They are destroyed along with the dead tissue in the alimentary tract of the larvae as the larvae feed on the necrotic tissue. The bacteria are also washed out of the ulcer as a result of the increased wound exudate caused by the irritant e¡ect of the larvae and the enzymatic liquefaction of necrotic tissue. Antibacterial agents are present in the larval secretions (7) . The antibacterial agents produced by the larvae are of interest, but have not yet been fully investigated. One of the interesting agents is allantoin, which is produced by the larvae and decreases bacterial counts, even though synthetically prepared allantoin has not been proved to have any direct bactericidal properties in ulcers (11) . Many studies are more than 50 years old, but newer investigations of the properties of larval secretions have been performed (12) . This is the ¢rst case reported in which larval therapy is thought to have played an essential part in the alteration of MRSA into common S. aureus as well as having an important impact on the healing of the ulcer. The time of bene¢cial e¡ect on both MRSA and the ulcer healing coincided with the larval application, supporting our belief that the larvae and no other factor was of importance.
